Article Details

Subcutaneous Trastuzumab Induces Immune Function in HER2+ Breast Cancer

Retrieved on: 2023-12-15 21:45:25

Tags for this article:

Click the tags to see associated articles and topics

Subcutaneous Trastuzumab Induces Immune Function in HER2+ Breast Cancer. View article details on hiswai:

Excerpt

In the IV trastuzumab arm, 20 of 31 patients (64.5%; 95% CI, 45.5%-80.1%) experienced a pathological complete response compared with 19 of 32 (59.4%; ...

Article found on: www.ajmc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo